<VariationArchive VariationID="10762" VariationName="NM_000169.3(GLA):c.194+1222_998dup" VariationType="Duplication" Accession="VCV000010762" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25801" VariationID="10762">
      <GeneList>
        <Gene Symbol="GLA" FullName="galactosidase alpha" GeneID="2717" HGNC_ID="HGNC:4296" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101397803" stop="101407925" display_start="101397803" display_stop="101407925" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100652778" stop="100663000" display_start="100652778" display_stop="100663000" Strand="-" />
          </Location>
          <OMIM>300644</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLA">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
        <Gene Symbol="RPL36A-HNRNPH2" FullName="RPL36A-HNRNPH2 readthrough" GeneID="100529097" HGNC_ID="HGNC:48349" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101391011" stop="101414133" display_start="101391011" display_stop="101414133" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100645877" stop="100669127" display_start="100645877" display_stop="100669127" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000169.3(GLA):c.194+1222_998dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101398370" stop="101398371" display_start="101398370" display_stop="101398371" variantLength="8118" positionVCF="101398370" referenceAlleleVCF="C" alternateAlleleVCF="CTGTCTAAGCTGGTACCCTTGCTTGCCCAAGGGGTCCTGATTGATGGCAATTACGTCCTTATCCTGAAGGAGAGCTTTGGCTTGAGGGCTGATGTGTCGGAGGTCATTAGACATGAATAAAGGAGCAGCCATGATAGCCCAGAGGGCCATCTGAGTTACTTGCTGATTCCAGCTGAGGCCAAAGTTGCCAATCACTAACTGAGAAAAAGAATGAAATAATTCAAACAAGAGAGGAGGAAACATTCTTAAAGTTACCTAGATGACCCATATGGAGAAACCACTTTCCACAGCATCCTGCTCTAAGTACTCTCACATAAAGCCTCCTCCCAGGAACTTTACCTGTATTTACCTTGAATGTCAAAATAGGAAACAAGCCTACCGCAGGGTCTTGAACAAGGAGGGCTCAAGTTTTTACCATATCTGGGTCATTCCAACCCCCTGGTCCAGCAACATCAACAATTCTCTCCTGGTTAAAAGATGTCCAGTCCAAGATACTCTTTATACTTTTCCAGGAATCATCAATGTCAGCAAAATTTCGCCAGTGATTGCAGTACTGTCGGATTTCTGTATAATTGGGCTGTGAAAACAGATATGACTCTTCTGTTTACTTTCTACTAACATCCTTGTGAGATGAAAACAGTTTAAAGGAGGCACTTGTAGCCTTCTCTTGAGTTTACAGATTGAACGTCTCCATAAGGAGGTCTAAACCCTTATAATGAATTTTCACTGTAAGAAGTTTGCTTCAGAAGTAGGCCATATAACTTGAAATCCCTTAAAGTTAATTTACTTCTATAATCAGAACTAAAATGGTCTTAGTAAAATTAAAAGCTGCAAAATTACATAGGACTCCATCAAGTATTAAGAAAACTTAAATCCCAGGCATATAGTTTGTTAATGGAATAAAAAGTTTGTAGAGGCTGGGCACGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCAGGTGGATCATCTGAGGTCAGGAGTTCGAGACAAGCCTGGCCAACATGGTGAAACCATCTCTACTAAAAATACAAAAATTAGCCAGATGTGGTAGCGCACGCCTATAATCCCAGCTACTGGGAGGCTGAGGCAAGAGAATCGCTTAAACCCGGGAGGCGGAGGTTGCAGTGAGCCGAGATGGCGCCACTGCACTCTAGCCTGGGTGACAGTGAGACTCTGTCGCAAAAAAAAAGTTTGTAGATAGGCAGGTGGGATATCAGGTTTAAGATGTTGAGAAAAAAGACTATTTTGCAGAGATAATGAGGGAATAATAGGGATTCATTCCATAAATAACTATTCAACACTTAACCATATGCGAGAGATACAGTCAAAGTCAGACAAGGTCCCTGCCCTCATGAAACTTACACTCTAGTGGGGAGACATGGTAACAAGTCAACAAATACTTCCAAATAGTGTGGAGCTCTGAGAAGAAAATTAAACAGGTTAATGTGATGAAGAATGAATGGACAGAGGGCTATTTTAAAGTAGTTAGAGAAGAACTGTCTGCATATGTGGCGTTTGGTCTGCGACTTCAATGTTAAGGAGCCCGGCCCTTTAAAAATCTTTGGGGAAGAACTGTTCTAGGCAGAAAAAAAGCAAGTGTAAAGGCCCTGGGGCAGCAATAGGCTTGCAGTGTTGAGGGACAGAAAGAAAACCAGTGTAGCCAGGGAAAGAGCCATGACCCCTTGGACTTTGGGGAGGCAGGCAAGGGCTGGATCAGTGCAGTTTGGTTTCATTCCAAGTGCAATTGGAAGCGAGTTAAGGGTTTTAAGCAGGGAACTGATGATGACATTTATATTTTTTATAACTCTGTTAAGTCTCAGGGTTTTTTTCTTTAAAAAAAAAACTGATATTTACATTTTAATATGATAACTCTAGTGCTGCTTGGAAAATAGATGGGGGTTGAGACAGAGTGGAAGCAGAGAGATCAGGTGGTCCCAGCAGTCTGGTTGAGAGCCGATAGTAGCTTGGAAGGCCAGGGTGCATGTAGTGAAGATGGAAGGAAGTGGGCTGATTCAGGAGATATTTTAGAGATACTGGTGGAAGGACTGTTGATAGACAGGACATGAATGGTGAAATAAAGGGGAAGACACAAGGATGACTTTCCAGGTGATGGTAGCTTAGGCTATAATTACAGCAGTGGGGATGGTGAGAAGTGGTTGGAACCTGGGAGAGATGGTAGGATGATAGTAAGTAACGTTGGACTTTGAAGGAGACCTTGGTTTCCTTTGTTGTCAAGTTCTATCTATCAGTACAGTTCTATTGGATTCTGGGCTCACTATCTCACCTTTTGAAAGGGCCACATATAAAGAGGCCACTCACAGGAGTACACAATGCTTCTGCCAGTCCTATTCAGGGCCAAGGACATGTGCTTATAACCTGTATGAGAAAACAATGGGTAAAATAAGGGAAAGAAATGAATTTCCAGCTGGGGCTATATATATAGTTATTTTATTTTATTTTATTTTAATTTTTTGAGATGGGGTTCAGTCTGTCATCCAGGGTGGAGTGCAGTGGTGCGATCTTGGCTCACTGCAACCTCTGTTTCCCAGGTTCAAGTGACTCTTCTGTCTCAGCTTCCCAAGTAGCTGGGATTACAGGCATGTGCCACCAAAGTCAGCTAATTTTTGTATTTTTACTAGAGATGGGGTTTCACCATGTTGGCCAGGGTGGTCTCGAACTCCTGACCTCAAGTAATCCACCCGCCTCAGCCTCCCAAAGTGCTAGGATTACAGGCATGAGCCATCATGCCCAGCTGGGGCTGTATATTTTAAGAAGAGGCTACCTGGAAGGTTCATGTTTAAACTAGCAGCAGGGACAGGCAGTTGCTCTGTGCTTAAATTGTGTAAAGTACCTCCCAGACTGCTGGGATTGTTCTGAGGAAGTAGTGCAGAGATGGTGTGTATATTGAGGAAAGGCAGGAATGAAGATGCTTCTTTCTCTGTGACCGATTGACAACCTGGACTCCCCTAAATGATGTTATAGAGAGTTACAATTACTAATTAACTCTTAGAGCCCTCTTGAATTATAAGTGCACAATATTAGCTATGGTTAGGTATGCATGGATTTTACATGAATTAATTAATTAATTAATGAACTGAAAGAGAAGAGATGGGAGCTCTGGCACATGGAGAATAATTATTTCCAGTATTGTGACAGGGTATTTAAAATTCTGAAGATTGGTTCTTTGGCTCAGCTACCATGGCCTCAAAGTTCTTTCCTTTGTGGCTAAATCTCTGGAATGAAACATTACCATCTGCCAAATTTTCCAAACTGTCACAGTAACAACCATCAAATTTTAGCAGATCTACTCCCCAGTCAGCAAAGGTCTGGGCATCAATGTCGTAGTATCCAAAACTCCCAGGGAAGCCTGCGCAGGTTTTATTTCCAACATCTGCATAAATCCCTAGCTTCAGTCCTTTGCTGTGAACCTGAAATGAGAGGGAGGAAAAGAGTCACCATTGTAGAAGCACAATCGTGAGGTAGCAGAAAGAGAGAACCATTCCAGGCTGGGGGAAGAGACAAGGTTACTTCACCAGGTATTGGGGGCTTTTCCCCACAAACCCCCAAAATCATCCAGATGAGTTTGTTGGAAGACAAAGAATAAATCCCCCAGTTCTGCTGAGCTAGTTCAAACTAGGCATGTGAGCTATAGCCCAGAACTGAGGAGAAAGCTAGCAGCCATGCTAATCTTCCTGATGGGATCCTGAAAATTACCTTTTGAGGGAAATGATAGATTTACCTTGACAAAGACTCTTCTTGACCAAACTTTAGTTAGACTTCTCTGATGAGCCTTCTTTTCGACTAGACCTCCACCTTGGCTTCCTATGTCTGTCCTAGCAAGACCTCTTAGCAAGAATCCTGCTAAGTCAATACTGCCACCATTGATATCTGATCAATTTCCCTCATCCCCCACCCTTCTTGTTTAAGTACATGAAGCTTTAGCAAGAAGCTCCCTACCCTTGATGTCTTCTTAAATATTCCATCCACTGACCCCCTCAATCTGCTCATTGGCTATAAATCTCCACCTGTCTTTGTTGTATTTGGAATTGAACTTGGCTCTTTCCTCTACTGTGGTAGTACTGAATAAAATCTGTCTTCATCGGCCGGGCGTGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGTGGGCGGATTACAAGGTCAGGAGTTCGAGACCAGCCTGGCGAATATGGTGAAACCTTGTCTCTACTAAAAATACAAAAATTAGCCGGGCGTGGTGGTGTGCGCCTGTAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATCACTTGAACCCAAGAGGTGGAGGGTTGCAGTGAGCTGAGATTGTGCCACTGCACTCCAGCCTGGGCGACAGAGCGAGACTCCGTCAAAAAAAAAAATCTGTCTTCATCATCTTTAACTAGTGTTGGACTCCATTTCTCTTCAATGATCTCCAGAATATTTTCCTTCTATCTTCTAAAATTCTAGTTTATAGTACCATTGCAATAGCTTCCTAAAGGTTATATGGAAATACATGCACACATATGTCAAGAACCAAGTTCCTTTTTCCTCCTAGAGAGTTCAGTGGTTTTAGCAAAAGGAGAACTCCAAGATGGGCCTCAAGAGCTATTACAAAACATTTGTAGGCTAGGCGCGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGTGGGCGGATCACGAGGTCAGGAGATCGAGACCATCTTGGCTAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAAATTAACTGGGCATGGTGGCGGGTGCCTGTGGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATGGCATGAACCCAGGAGGTGGAGCTTGCAGTGAGCCGAGATCGCACCACTGCCCTCCAGCCTGGGAGACAGAATGAGACTCCATCTCAAAAAAAAAAAAAAAAAAAAATTGTCTGCTGATGGAATGCAAAGTCCACCTGATAAGCCTTACAATTCAATGTTCAGATAACAGCCAGCTATTCTACTTTCTAAGTGTCATGAGGGCTGTTTCTTTTTTTCCTTGTTTTTTTTTTTGAGATGGAGTTTCTCTTTTGTTGCCCAGGCTAGAGTGCAATGGCGTGATCTCAGCTCACTGAAACTTCCACCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGGTTACAGGCGTTCACCACCATGCCCAGCTAATTTTTTGTACTTTTAATAGAGTTGGGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCTTGACCTCAGGTGATCCACCCGCCTCGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACGCCCGGCCATGAGGGCTGTTTCTAAACAAGCTTCTGTACAGAAGTGCTTACAGTCCTCTGAATGAACAAGAACATTATCTATAAACTCACATAATTAGCTAGCTGGCGAATCCCATGAGGAAAGCGCTGAGGGTCTGCCTGAAGTCTGCCTTCTGAATCTCTTTGGGGAGCCATCCAACAGTCATCAATGCAGAGGTACTCATAACCTGCATCCTTCCAGCCTTCTGAGACCATGAGCTCTGCCATCTCCATGAAGAGCTTCTCACTGAAAGAGAAATTCCAATAATCATTACAATTCATTAAATGAACACTTAGGTACCTCCCATTTATTAGGCACCTTGGGATTTCACAATTTTTTCCAACCCAGTAATAGTGTGGTAGTAATCACAAGCAATGTAAGGTAAAATGAATTGTTTTTCCAGATTTTCTTTTGTCTCTCTTATCCCGTTAATATTCCCGCCCTAAAAACCCCAAACAAAATAGGAATGAGAAATATATGATGAAATTGAAAAGAGTATTAGATCTAAGAAGACAGTTCAGTAAAGTCAGAAACTACAAAGTTAACATAATCAACAGATATCAACAATAATCCTATTTGGAGAAAAAGATCCCATTCACAAGAACAACTGAACAACCTAAAATGCCTAGAGATAAATTTAAGATACGTGCAAGGCCCATATGTTAAAACTATGATGCTCCTAAATGATTTGAATAAATGGAGAAATATTATTTTGCTCTTGGATAAGCATACTCAATATTAAAAATAAGTTAATTTTCCCTGCAATCCTTTGTATATTTAACAAAATCCTTAACAAAGCCCAAGAGTACTTAGGTTTCCTTTTTATCTTTTTTTTTTTTTTTTTTTTTGAGATGGAGTCTCCCTCTGTCACCCAGGCTGGAGTGCAGTGGCGCCATCTTGGCTCACTGCAACCTCTGCCTCCCCGGTTCAAGCGATTCTTCTACCTCAGCCTCCCGAGTAGCTGAGATTACAGGCATGTGCCATCGCATCCGGCTAATTTTTGTATCTTTAGTAGAGACAGGGTTTTGCATTTTGGCTAGGCTAGTCTTGAACTCCTGGCCTCAAGTGATCCACCTGCCTCAGACTCCCAAAATGCTGGGATTACAGGCGTGGGCCACCTGCCCAGCTTCCAAAAGGGCTTTTTAAGGAACTTGGCACAACATTACAAAAAGTTCACCTAAAAGATTACATACATGTACATTCATTAAAAGATGAAGGCTGGGCGTGGTGGCTCACGCCTGTAATAACAGCATTTTGGGAGGCCGAGGCAGGCAGATCACCTGAGGCTGGGAGTTTGAGACCAGCCTGACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATAGCTAGGCGTGGTGGCGCATGCCTGTAATTCCAGCTACTCGCGAGGATGAGGCAGGAGAATTGCTTGAACCTGGGAGGCGGAGGTTGCGGTGAACCGAGATCGTGACATTGTACTCCAGCCTGGGCAACAAGAGCGAAACTCCAGCTCAAAAAAAAAAAAAAAAAGAAAAAAAAGATAAAGGAAGCTAGTGTGGAACTATTAGCATTAGAATAAGAATACACAGATTAATGGAATTAAACAAAGTTTCGAAAGAGGTCCTTCCAGCCATCTGATACCATGGGACTTATTATTTATTAAATGTGGCATTTCTGATAGAAGAACAAAGTTCAGATGGACTAAAGATTTAAATATTTTAAAAATCCACAAAAATACTAGTAAGAAACGTATATACTGTATTATCTTCAGGTAGGAAAGGACTTTCTCAGCATGACCCCAAAGTCAGAAATCAGAAAGGAAAAACTGATGTGTTTGATTACATAAATATCAAAACCAACACATAGGAAGAACCACTGTATTTGCAAGGTATGATAGACTAAAAAAGAAAAAAGAGGCCGGGTGCGGTGGCTCACACCTGTAATCCCAGCACTCTGGGAGGCCAAGGCGGGCAGATCACTTGAGGCCAGGAGTTCGAGACCAGCTTGGGCAACATGGTGAAACCCGTCTCTACTGAAAATACAAAAATTAGCTGGCCGTGGTGGTGTGCCTGTAATCCCAGCTACTCAGGAGACTACGACAGGAGAACTGCTTAAACCCGGGAGGTGGAGTTTGCACTGAGCAGAGATCGCGCCACTGCACTCCAACCTGGGTGACAGAGTGAGACCCCCTCTCAAAAAAAAAAGTAAGGCTGGGCACGGTGGCTCACACCAGCACTTTGGGAGGCTGAGGCGGGCGAATCACGAGGTCAGGAGATTGAGACCACCCTGGCTAACATGGTGAAACCCCGTCTGTACTAAAAAAAAAAAAAAAAAAAAAAAGAGCCAGGCGTGGTGGCAGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGAAGAATGGCGTGAACCCAGGAGGCGGAGCTTGCAGTGAGCCGAGATCGTGCCACTGCACTCCAGCCTGGGCGACAGAGCGAGACCCCGTCTCAAAAAAAAAAAAAAAAAAAAAGTGTAATTTACCCAATGTCACAGGGCTAAGTAACAATGAGGCAGAATTTGAGCCCAGACTGGGTGCCAGGGTCTTGCCATTAGCCAAACATGACATAAACATGATCCATTTTTTATGGAAAATAATGAAATAAAGAAATCTATGTTTTCATTTATATAGAAAACAATTGTAAGGTTGTATATTAACATTTAAACCATGATTATTTCTGGGTGGTGGAACGGTGGGGGGAAATCTTTATTTTCATTTTGCTCTTCTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100653358" stop="100653359" display_start="100653358" display_stop="100653359" variantLength="8118" positionVCF="100653358" referenceAlleleVCF="C" alternateAlleleVCF="CTGTCTAAGCTGGTACCCTTGCTTGCCCAAGGGGTCCTGATTGATGGCAATTACGTCCTTATCCTGAAGGAGAGCTTTGGCTTGAGGGCTGATGTGTCGGAGGTCATTAGACATGAATAAAGGAGCAGCCATGATAGCCCAGAGGGCCATCTGAGTTACTTGCTGATTCCAGCTGAGGCCAAAGTTGCCAATCACTAACTGAGAAAAAGAATGAAATAATTCAAACAAGAGAGGAGGAAACATTCTTAAAGTTACCTAGATGACCCATATGGAGAAACCACTTTCCACAGCATCCTGCTCTAAGTACTCTCACATAAAGCCTCCTCCCAGGAACTTTACCTGTATTTACCTTGAATGTCAAAATAGGAAACAAGCCTACCGCAGGGTCTTGAACAAGGAGGGCTCAAGTTTTTACCATATCTGGGTCATTCCAACCCCCTGGTCCAGCAACATCAACAATTCTCTCCTGGTTAAAAGATGTCCAGTCCAAGATACTCTTTATACTTTTCCAGGAATCATCAATGTCAGCAAAATTTCGCCAGTGATTGCAGTACTGTCGGATTTCTGTATAATTGGGCTGTGAAAACAGATATGACTCTTCTGTTTACTTTCTACTAACATCCTTGTGAGATGAAAACAGTTTAAAGGAGGCACTTGTAGCCTTCTCTTGAGTTTACAGATTGAACGTCTCCATAAGGAGGTCTAAACCCTTATAATGAATTTTCACTGTAAGAAGTTTGCTTCAGAAGTAGGCCATATAACTTGAAATCCCTTAAAGTTAATTTACTTCTATAATCAGAACTAAAATGGTCTTAGTAAAATTAAAAGCTGCAAAATTACATAGGACTCCATCAAGTATTAAGAAAACTTAAATCCCAGGCATATAGTTTGTTAATGGAATAAAAAGTTTGTAGAGGCTGGGCACGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCAGGTGGATCATCTGAGGTCAGGAGTTCGAGACAAGCCTGGCCAACATGGTGAAACCATCTCTACTAAAAATACAAAAATTAGCCAGATGTGGTAGCGCACGCCTATAATCCCAGCTACTGGGAGGCTGAGGCAAGAGAATCGCTTAAACCCGGGAGGCGGAGGTTGCAGTGAGCCGAGATGGCGCCACTGCACTCTAGCCTGGGTGACAGTGAGACTCTGTCGCAAAAAAAAAGTTTGTAGATAGGCAGGTGGGATATCAGGTTTAAGATGTTGAGAAAAAAGACTATTTTGCAGAGATAATGAGGGAATAATAGGGATTCATTCCATAAATAACTATTCAACACTTAACCATATGCGAGAGATACAGTCAAAGTCAGACAAGGTCCCTGCCCTCATGAAACTTACACTCTAGTGGGGAGACATGGTAACAAGTCAACAAATACTTCCAAATAGTGTGGAGCTCTGAGAAGAAAATTAAACAGGTTAATGTGATGAAGAATGAATGGACAGAGGGCTATTTTAAAGTAGTTAGAGAAGAACTGTCTGCATATGTGGCGTTTGGTCTGCGACTTCAATGTTAAGGAGCCCGGCCCTTTAAAAATCTTTGGGGAAGAACTGTTCTAGGCAGAAAAAAAGCAAGTGTAAAGGCCCTGGGGCAGCAATAGGCTTGCAGTGTTGAGGGACAGAAAGAAAACCAGTGTAGCCAGGGAAAGAGCCATGACCCCTTGGACTTTGGGGAGGCAGGCAAGGGCTGGATCAGTGCAGTTTGGTTTCATTCCAAGTGCAATTGGAAGCGAGTTAAGGGTTTTAAGCAGGGAACTGATGATGACATTTATATTTTTTATAACTCTGTTAAGTCTCAGGGTTTTTTTCTTTAAAAAAAAAACTGATATTTACATTTTAATATGATAACTCTAGTGCTGCTTGGAAAATAGATGGGGGTTGAGACAGAGTGGAAGCAGAGAGATCAGGTGGTCCCAGCAGTCTGGTTGAGAGCCGATAGTAGCTTGGAAGGCCAGGGTGCATGTAGTGAAGATGGAAGGAAGTGGGCTGATTCAGGAGATATTTTAGAGATACTGGTGGAAGGACTGTTGATAGACAGGACATGAATGGTGAAATAAAGGGGAAGACACAAGGATGACTTTCCAGGTGATGGTAGCTTAGGCTATAATTACAGCAGTGGGGATGGTGAGAAGTGGTTGGAACCTGGGAGAGATGGTAGGATGATAGTAAGTAACGTTGGACTTTGAAGGAGACCTTGGTTTCCTTTGTTGTCAAGTTCTATCTATCAGTACAGTTCTATTGGATTCTGGGCTCACTATCTCACCTTTTGAAAGGGCCACATATAAAGAGGCCACTCACAGGAGTACACAATGCTTCTGCCAGTCCTATTCAGGGCCAAGGACATGTGCTTATAACCTGTATGAGAAAACAATGGGTAAAATAAGGGAAAGAAATGAATTTCCAGCTGGGGCTATATATATAGTTATTTTATTTTATTTTATTTTAATTTTTTGAGATGGGGTTCAGTCTGTCATCCAGGGTGGAGTGCAGTGGTGCGATCTTGGCTCACTGCAACCTCTGTTTCCCAGGTTCAAGTGACTCTTCTGTCTCAGCTTCCCAAGTAGCTGGGATTACAGGCATGTGCCACCAAAGTCAGCTAATTTTTGTATTTTTACTAGAGATGGGGTTTCACCATGTTGGCCAGGGTGGTCTCGAACTCCTGACCTCAAGTAATCCACCCGCCTCAGCCTCCCAAAGTGCTAGGATTACAGGCATGAGCCATCATGCCCAGCTGGGGCTGTATATTTTAAGAAGAGGCTACCTGGAAGGTTCATGTTTAAACTAGCAGCAGGGACAGGCAGTTGCTCTGTGCTTAAATTGTGTAAAGTACCTCCCAGACTGCTGGGATTGTTCTGAGGAAGTAGTGCAGAGATGGTGTGTATATTGAGGAAAGGCAGGAATGAAGATGCTTCTTTCTCTGTGACCGATTGACAACCTGGACTCCCCTAAATGATGTTATAGAGAGTTACAATTACTAATTAACTCTTAGAGCCCTCTTGAATTATAAGTGCACAATATTAGCTATGGTTAGGTATGCATGGATTTTACATGAATTAATTAATTAATTAATGAACTGAAAGAGAAGAGATGGGAGCTCTGGCACATGGAGAATAATTATTTCCAGTATTGTGACAGGGTATTTAAAATTCTGAAGATTGGTTCTTTGGCTCAGCTACCATGGCCTCAAAGTTCTTTCCTTTGTGGCTAAATCTCTGGAATGAAACATTACCATCTGCCAAATTTTCCAAACTGTCACAGTAACAACCATCAAATTTTAGCAGATCTACTCCCCAGTCAGCAAAGGTCTGGGCATCAATGTCGTAGTATCCAAAACTCCCAGGGAAGCCTGCGCAGGTTTTATTTCCAACATCTGCATAAATCCCTAGCTTCAGTCCTTTGCTGTGAACCTGAAATGAGAGGGAGGAAAAGAGTCACCATTGTAGAAGCACAATCGTGAGGTAGCAGAAAGAGAGAACCATTCCAGGCTGGGGGAAGAGACAAGGTTACTTCACCAGGTATTGGGGGCTTTTCCCCACAAACCCCCAAAATCATCCAGATGAGTTTGTTGGAAGACAAAGAATAAATCCCCCAGTTCTGCTGAGCTAGTTCAAACTAGGCATGTGAGCTATAGCCCAGAACTGAGGAGAAAGCTAGCAGCCATGCTAATCTTCCTGATGGGATCCTGAAAATTACCTTTTGAGGGAAATGATAGATTTACCTTGACAAAGACTCTTCTTGACCAAACTTTAGTTAGACTTCTCTGATGAGCCTTCTTTTCGACTAGACCTCCACCTTGGCTTCCTATGTCTGTCCTAGCAAGACCTCTTAGCAAGAATCCTGCTAAGTCAATACTGCCACCATTGATATCTGATCAATTTCCCTCATCCCCCACCCTTCTTGTTTAAGTACATGAAGCTTTAGCAAGAAGCTCCCTACCCTTGATGTCTTCTTAAATATTCCATCCACTGACCCCCTCAATCTGCTCATTGGCTATAAATCTCCACCTGTCTTTGTTGTATTTGGAATTGAACTTGGCTCTTTCCTCTACTGTGGTAGTACTGAATAAAATCTGTCTTCATCGGCCGGGCGTGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGTGGGCGGATTACAAGGTCAGGAGTTCGAGACCAGCCTGGCGAATATGGTGAAACCTTGTCTCTACTAAAAATACAAAAATTAGCCGGGCGTGGTGGTGTGCGCCTGTAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATCACTTGAACCCAAGAGGTGGAGGGTTGCAGTGAGCTGAGATTGTGCCACTGCACTCCAGCCTGGGCGACAGAGCGAGACTCCGTCAAAAAAAAAAATCTGTCTTCATCATCTTTAACTAGTGTTGGACTCCATTTCTCTTCAATGATCTCCAGAATATTTTCCTTCTATCTTCTAAAATTCTAGTTTATAGTACCATTGCAATAGCTTCCTAAAGGTTATATGGAAATACATGCACACATATGTCAAGAACCAAGTTCCTTTTTCCTCCTAGAGAGTTCAGTGGTTTTAGCAAAAGGAGAACTCCAAGATGGGCCTCAAGAGCTATTACAAAACATTTGTAGGCTAGGCGCGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGTGGGCGGATCACGAGGTCAGGAGATCGAGACCATCTTGGCTAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAAATTAACTGGGCATGGTGGCGGGTGCCTGTGGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATGGCATGAACCCAGGAGGTGGAGCTTGCAGTGAGCCGAGATCGCACCACTGCCCTCCAGCCTGGGAGACAGAATGAGACTCCATCTCAAAAAAAAAAAAAAAAAAAAATTGTCTGCTGATGGAATGCAAAGTCCACCTGATAAGCCTTACAATTCAATGTTCAGATAACAGCCAGCTATTCTACTTTCTAAGTGTCATGAGGGCTGTTTCTTTTTTTCCTTGTTTTTTTTTTTGAGATGGAGTTTCTCTTTTGTTGCCCAGGCTAGAGTGCAATGGCGTGATCTCAGCTCACTGAAACTTCCACCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGGTTACAGGCGTTCACCACCATGCCCAGCTAATTTTTTGTACTTTTAATAGAGTTGGGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCTTGACCTCAGGTGATCCACCCGCCTCGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACGCCCGGCCATGAGGGCTGTTTCTAAACAAGCTTCTGTACAGAAGTGCTTACAGTCCTCTGAATGAACAAGAACATTATCTATAAACTCACATAATTAGCTAGCTGGCGAATCCCATGAGGAAAGCGCTGAGGGTCTGCCTGAAGTCTGCCTTCTGAATCTCTTTGGGGAGCCATCCAACAGTCATCAATGCAGAGGTACTCATAACCTGCATCCTTCCAGCCTTCTGAGACCATGAGCTCTGCCATCTCCATGAAGAGCTTCTCACTGAAAGAGAAATTCCAATAATCATTACAATTCATTAAATGAACACTTAGGTACCTCCCATTTATTAGGCACCTTGGGATTTCACAATTTTTTCCAACCCAGTAATAGTGTGGTAGTAATCACAAGCAATGTAAGGTAAAATGAATTGTTTTTCCAGATTTTCTTTTGTCTCTCTTATCCCGTTAATATTCCCGCCCTAAAAACCCCAAACAAAATAGGAATGAGAAATATATGATGAAATTGAAAAGAGTATTAGATCTAAGAAGACAGTTCAGTAAAGTCAGAAACTACAAAGTTAACATAATCAACAGATATCAACAATAATCCTATTTGGAGAAAAAGATCCCATTCACAAGAACAACTGAACAACCTAAAATGCCTAGAGATAAATTTAAGATACGTGCAAGGCCCATATGTTAAAACTATGATGCTCCTAAATGATTTGAATAAATGGAGAAATATTATTTTGCTCTTGGATAAGCATACTCAATATTAAAAATAAGTTAATTTTCCCTGCAATCCTTTGTATATTTAACAAAATCCTTAACAAAGCCCAAGAGTACTTAGGTTTCCTTTTTATCTTTTTTTTTTTTTTTTTTTTTGAGATGGAGTCTCCCTCTGTCACCCAGGCTGGAGTGCAGTGGCGCCATCTTGGCTCACTGCAACCTCTGCCTCCCCGGTTCAAGCGATTCTTCTACCTCAGCCTCCCGAGTAGCTGAGATTACAGGCATGTGCCATCGCATCCGGCTAATTTTTGTATCTTTAGTAGAGACAGGGTTTTGCATTTTGGCTAGGCTAGTCTTGAACTCCTGGCCTCAAGTGATCCACCTGCCTCAGACTCCCAAAATGCTGGGATTACAGGCGTGGGCCACCTGCCCAGCTTCCAAAAGGGCTTTTTAAGGAACTTGGCACAACATTACAAAAAGTTCACCTAAAAGATTACATACATGTACATTCATTAAAAGATGAAGGCTGGGCGTGGTGGCTCACGCCTGTAATAACAGCATTTTGGGAGGCCGAGGCAGGCAGATCACCTGAGGCTGGGAGTTTGAGACCAGCCTGACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATAGCTAGGCGTGGTGGCGCATGCCTGTAATTCCAGCTACTCGCGAGGATGAGGCAGGAGAATTGCTTGAACCTGGGAGGCGGAGGTTGCGGTGAACCGAGATCGTGACATTGTACTCCAGCCTGGGCAACAAGAGCGAAACTCCAGCTCAAAAAAAAAAAAAAAAAGAAAAAAAAGATAAAGGAAGCTAGTGTGGAACTATTAGCATTAGAATAAGAATACACAGATTAATGGAATTAAACAAAGTTTCGAAAGAGGTCCTTCCAGCCATCTGATACCATGGGACTTATTATTTATTAAATGTGGCATTTCTGATAGAAGAACAAAGTTCAGATGGACTAAAGATTTAAATATTTTAAAAATCCACAAAAATACTAGTAAGAAACGTATATACTGTATTATCTTCAGGTAGGAAAGGACTTTCTCAGCATGACCCCAAAGTCAGAAATCAGAAAGGAAAAACTGATGTGTTTGATTACATAAATATCAAAACCAACACATAGGAAGAACCACTGTATTTGCAAGGTATGATAGACTAAAAAAGAAAAAAGAGGCCGGGTGCGGTGGCTCACACCTGTAATCCCAGCACTCTGGGAGGCCAAGGCGGGCAGATCACTTGAGGCCAGGAGTTCGAGACCAGCTTGGGCAACATGGTGAAACCCGTCTCTACTGAAAATACAAAAATTAGCTGGCCGTGGTGGTGTGCCTGTAATCCCAGCTACTCAGGAGACTACGACAGGAGAACTGCTTAAACCCGGGAGGTGGAGTTTGCACTGAGCAGAGATCGCGCCACTGCACTCCAACCTGGGTGACAGAGTGAGACCCCCTCTCAAAAAAAAAAGTAAGGCTGGGCACGGTGGCTCACACCAGCACTTTGGGAGGCTGAGGCGGGCGAATCACGAGGTCAGGAGATTGAGACCACCCTGGCTAACATGGTGAAACCCCGTCTGTACTAAAAAAAAAAAAAAAAAAAAAAAGAGCCAGGCGTGGTGGCAGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGAAGAATGGCGTGAACCCAGGAGGCGGAGCTTGCAGTGAGCCGAGATCGTGCCACTGCACTCCAGCCTGGGCGACAGAGCGAGACCCCGTCTCAAAAAAAAAAAAAAAAAAAAAGTGTAATTTACCCAATGTCACAGGGCTAAGTAACAATGAGGCAGAATTTGAGCCCAGACTGGGTGCCAGGGTCTTGCCATTAGCCAAACATGACATAAACATGATCCATTTTTTATGGAAAATAATGAAATAAAGAAATCTATGTTTTCATTTATATAGAAAACAATTGTAAGGTTGTATATTAACATTTAAACCATGATTATTTCTGGGTGGTGGAACGGTGGGGGGAAATCTTTATTTTCATTTTGCTCTTCTT" />
      </Location>
      <OtherNameList>
        <Name>GLA, EX2-6DUP</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.100653360_100661477dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.100653360_100661477dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.101398372_101406489dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.101398372_101406489dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007119.1" sequenceAccession="NG_007119" sequenceVersion="1" change="g.6476_14593dup">
            <Expression>NG_007119.1:g.6476_14593dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199973.2" sequenceAccession="NM_001199973" sequenceVersion="2" change="c.300+2915_301-5447dup">
            <Expression>NM_001199973.2:c.300+2915_301-5447dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199974.2" sequenceAccession="NM_001199974" sequenceVersion="2" change="c.177+6550_178-5447dup">
            <Expression>NM_001199974.2:c.177+6550_178-5447dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000169.3" sequenceAccession="NM_000169" sequenceVersion="3" change="c.194+1222_998dup" MANESelect="true">
            <Expression>NM_000169.3:c.194+1222_998dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_672" sequenceAccession="LRG_672">
            <Expression>LRG_672:g.6476_14593dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300644.0050" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 300644.0050 from the sequence reported in Figure 2 of the paper by Kornreich et al., 1990 (PubMed 2160973).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000169.3(GLA):c.194+1222_998dup AND Fabry disease" Accession="RCV000011509" Version="6">
        <ClassifiedConditionList TraitSetID="3012">
          <ClassifiedCondition DB="MedGen" ID="C0002986">Fabry disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1990-06-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1990-06-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2160973</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3012" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1790" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fabry's disease</ElementValue>
                <XRef ID="Fabry+Disease/2690" DB="Genetic Alliance" />
                <XRef ID="16652001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Angiokeratoma, diffuse</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anderson-Fabry disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary dystopic lipidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha-galactosidase A deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Angiokeratoma corporis diffusum</ElementValue>
                <XRef ID="HP:0001071" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceramide trihexosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceramide trihexosidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fabry disease</ElementValue>
                <XRef ID="MONDO:0010526" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6400" />
                <XRef ID="6400" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.</Attribute>
                <XRef ID="GTR000500007" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507480" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520414" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512526" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514924" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568367" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596367" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552214" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505068" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528516" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528528" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325415" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556501" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520447" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260631" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fabry disease is the most common of the lysosomal storage disorders and results from deficient activity of the enzyme alpha-galactosidase A (α-Gal A), leading to progressive lysosomal deposition of globotriaosylceramide and its derivatives in cells throughout the body. The classic form, occurring in males with less than 1% α-Gal A enzyme activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesia), the appearance of vascular cutaneous lesions (angiokeratomas), sweating abnormalities (anhidrosis, hypohidrosis, and rarely hyperhidrosis), characteristic corneal and lenticular opacities, and proteinuria. Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in men in the third to fifth decade. In middle age, most males successfully treated for ESRD develop cardiac and/or cerebrovascular disease, a major cause of morbidity and mortality. Heterozygous females typically have milder symptoms at a later age of onset than males. Rarely, females may be relatively asymptomatic throughout a normal life span or may have symptoms as severe as those observed in males with the classic phenotype. In contrast, late-onset forms occur in males with greater than 1% α-Gal A activity. Clinical manifestations include cardiac disease, which usually presents in the sixth to eighth decade with left ventricular hypertrophy, cardiomyopathy, arrhythmia, and proteinuria; renal failure, associated with ESRD but without the skin lesions or pain; or cerebrovascular disease presenting as stroke or transient ischemic attack.</Attribute>
                <XRef ID="NBK1292" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301469</ID>
                <ID Source="BookShelf">NBK1292</ID>
              </Citation>
              <Citation Type="general">
                <ID Source="pmc">3009617</ID>
              </Citation>
              <Citation Type="general" Abbrev="HFSA, 2010">
                <ID Source="PubMed">20610207</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2002">
                <ID Source="PubMed">12735292</ID>
              </Citation>
              <Citation Type="general" Abbrev="Eng et al., 2006">
                <ID Source="PubMed">16980809</ID>
              </Citation>
              <Citation Type="general" Abbrev="Salviati et al, 2010">
                <ID Source="pmc">2869001</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21934708</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2013">
                <ID Source="PubMed">23860966</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ACC/HFSA, 2022">
                <ID Source="PubMed">35378257</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACC/AHA/HFSA, 2017">
                <ID Source="PubMed">28461259</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Fabry.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased a-galactosidase A, Fabry Disease, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Fabry-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Alpha-galactosidase A (alpha- gal A) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="324" DB="Orphanet" />
              <XRef ID="C0002986" DB="MedGen" />
              <XRef ID="MONDO:0010526" DB="MONDO" />
              <XRef Type="MIM" ID="301500" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001071" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31741" SubmissionDate="2010-12-08" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300644.0050_FABRY DISEASE" title="GLA, EX2-6DUP_FABRY DISEASE" />
        <ClinVarAccession Accession="SCV000031741" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1990-06-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an English patient with severe Fabry disease (301500), Kornreich et al. (1990) found a duplication of 8.1 kb that included exons 2 to 5 and part of exon 6 of the GLA gene. The duplicated area was flanked by a TAGACA direct repeat.</Attribute>
              <Citation>
                <ID Source="PubMed">2160973</ID>
              </Citation>
              <XRef DB="OMIM" ID="301500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLA" />
          </GeneList>
          <Name>GLA, EX2-6DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX2-6DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300644.0050" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FABRY DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31741" TraitType="Disease" MappingType="Name" MappingValue="FABRY DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0002986" Name="Fabry disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

